fenoxycarb has been researched along with Multiple Myeloma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kuroda, J; Shimura, Y | 1 |
| Guziolowski, C; Magrangeas, F; Miannay, B; Minvielle, S | 1 |
| Abernethy, DR; Chudasama, VL; Mager, DE; Ovacik, MA | 1 |
3 other study(ies) available for fenoxycarb and Multiple Myeloma
| Article | Year |
|---|---|
[Ⅲ.Therapeutic Strategy for Relapsed/Refractory Multiple Myeloma-The Logic and Practice].
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Logic; Multiple Myeloma; Neoplasm Recurrence, Local; Recurrence; Treatment Outcome | 2020 |
Constraints on signaling network logic reveal functional subgraphs on Multiple Myeloma OMIC data.
Topics: Computational Biology; Computer Graphics; Gene Regulatory Networks; Logic; Models, Biological; Multiple Myeloma; Signal Transduction | 2018 |
Logic-Based and Cellular Pharmacodynamic Modeling of Bortezomib Responses in U266 Human Myeloma Cells.
Topics: Apoptosis; bcl-X Protein; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Humans; Logic; Multiple Myeloma; NF-kappa B; Poly(ADP-ribose) Polymerases; Pyrazines; Signal Transduction | 2015 |